Clinical Trial Update: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraamniotic administration of ER004 in male subjects with X-linked hypohidrotic ectodermal dysplasia; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Hypohidrotic Ectodermal Dysplasia

Drugs mentioned

• ER004

Snippet

Sponsor: EspeRare Foundation | Conditions: X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) | Phase 2 | Status: RECRUITING